China’s COVID-19 Timeline Questioned After Official Claims to Be Vaccinated in March 2020
The timeline of the COVID-19 outbreak published by the Chinese Communist Party (CCP) has been questioned by experts after an official claimed on March 5 that many executives in his company took an experimental CCP virus vaccine in March 2020.
Yu Qingming, party secretary and CEO of Sinopharm Group Co., Ltd. (Sinopharm) claimed that executives and senior leaders of China National Pharmaceutical Group (CNPG), the parent company of Sinopharm, had received the vaccines developed by the group as early as March 2020.
Sinopharm is a Chinese state-owned pharmaceutical company.
Yu also claimed that the antibody level remains high after one year.
Sinopharm Chairman Claims He Received COVID-19 Vaccine One Year Ago, Has Antibodies
Yu Qingming, party chief and chairman of Sinopharm, told Chinese state media on March 4 that he and others at the firm’s management received CCP (Chinese Communist Party) virus vaccines a year ago and still have a high level of antibodies. His claim ignited a heated discussion over the origins of the virus strains and the timeline of China’s vaccine development.
Sinopharm is also known as China National Pharmaceutical Group Corporation, a Beijing-based Chinese state-owned enterprise.
Yu, who is also a deputy to China’s National People’s Congress, told the People’s Daily during the Two Sessions the CCP’s most important annual political conference from March 4 to 11 that in March 2020, Sinopharm management received COVID-19 vaccines and still have high levels of antibodies after one year of continuous monitoring.
Industry insiders refute ill-intended hype on early inoculation of Sinopharm Group s leaders, owe speed to mature technology, urgent situation
Wang Qi and Leng Shumei Published: Mar 09, 2021 09:12 PM
Workers unload a container of China s Sinopharm inactivated coronavirus vaccines at the Belgrade Airport, Serbia, January 16, 2021. Photo: Xinhua
The recent disclosure by China s pharmaceutical giant Sinopharm Group boss Yu Qingming that some of the firm s leaders received the COVID-19 vaccine as early as March 2020, about three months after the outbreak started in Wuhan, Central China s Hubei Province, amazed many, while also prompting some ill-intended Western media hype of a conspiracy theory.
However, industry insiders and vaccine experts reached by the Global Times on Tuesday pointed out that such speedy vaccine progress is a result of China s mastering of mature inactivated vaccine technology and researchers determination amid an urgent need at the early stage of the outbrea
China's production capacity of COVID-19 vaccines could be sufficient to supply enough doses for 40% of the population by mid-2021, the country's head of disease control authorities said on Friday.
<div class="at-above-post addthis tool" data-url="https://www.metro.us/chinas-covid-19-vaccine-production/"></div>BEIJING (Reuters) – China’s production capacity of COVID-19 vaccines could be sufficient for 40% of the population to have been vaccinated by mid-2021, the country’s head of disease control authorities said on Friday. The country’s production capacity may also be large enough to allow 70%-80% of its 1.4 billion population to have been vaccinated by […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/chinas-covid-19-